| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/31/2008 | WO2006041959A8 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027139 Use of Alpha-Ketoglutarate and Related Compounds |
| 01/31/2008 | US20080027116 Pharmaceutical Composition for Treating Spinocerebellar Ataxia |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027020 Human Neuropeptide Receptor |
| 01/31/2008 | US20080027008 Antitumorigenic Drug Combination |
| 01/31/2008 | US20080027007 treating radiation injury damage of the lining of the intestinal tract of a subject in need thereof by administering to the subject a peptide consisting of the amino acid sequence AQGV |
| 01/31/2008 | US20080027006 Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity |
| 01/31/2008 | US20080027005 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/31/2008 | US20080027004 Phosphorylated COP1 molecules and uses thereof |
| 01/31/2008 | US20080027003 Peptides Useful for Treating Gnrh Associated Diseases |
| 01/31/2008 | US20080027002 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | US20080027000 APO-A-I Regulation of T-Cell Signaling |
| 01/31/2008 | US20080026999 Dehydration, cyclization of peptide; prevention, therapy for bacteria infections; amino acid sequences |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026997 Medicament for the Treatment of Fungal Infections Particularly Aspergillosis |
| 01/31/2008 | US20080026996 Selective Vpac2 Receptor Reptide Agonists |
| 01/31/2008 | US20080026995 Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 01/31/2008 | US20080026994 Modified vitamin K-dependent polypeptides |
| 01/31/2008 | US20080026993 Modified growth hormones |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026991 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080026990 18-Membered Nitrobenzyl- and Aminobenzyl-Substituted Cyclohexadepsipeptides for Controlling Endoparasites and a Process for Their Preparation |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026988 Compositions and methods for human immunodeficiency virus vaccination |
| 01/31/2008 | US20080026987 Use of Liver-Selective Glucokinase Activators |
| 01/31/2008 | US20080026986 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling |
| 01/31/2008 | US20080026985 Control of gene expression |
| 01/31/2008 | US20080026984 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 01/31/2008 | US20080026983 Compositions and methods for alleviating joint pain and improving joint flexibility |
| 01/31/2008 | US20080026982 Mutant APOBEC3G molecules for inhibiting replication of HIV |
| 01/31/2008 | US20080026981 Pharmaceutical Compositions |
| 01/31/2008 | US20080026980 Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases |
| 01/31/2008 | US20080026459 Differential expression via marker within genome; fluorescence activated cell sorting |
| 01/31/2008 | US20080026446 Combination of a growth factor and a protease enzyme |
| 01/31/2008 | US20080026444 Process For Producing Protein-Polymer Complex |
| 01/31/2008 | US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF |
| 01/31/2008 | US20080026426 Anti-infective therapy |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026401 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
| 01/31/2008 | US20080026077 Methods and compositions of gene delivery agents for systemic and local therapy |
| 01/31/2008 | US20080026074 Method of short term skin wrinkles correction using strontium divalent ion |
| 01/31/2008 | US20080026072 glycoproteins having alpha 1,4-linked N-acetylglucosamine residue from milk of mammal containing carrier polypeptide with alpha 1,4-N-acetylglucosaminyl transferase; for treatment or prevention of gastric ulcers |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026068 Pulmonary delivery of spherical insulin microparticles |
| 01/31/2008 | US20080026065 Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State |
| 01/31/2008 | US20080026046 Stable Aqueous G-Csf Conatining Compositions |
| 01/31/2008 | US20080026032 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
| 01/31/2008 | US20080026017 Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof |
| 01/31/2008 | US20080026014 Nasal Stick for the Application of Medicaments and Skin Care Substances |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026003 Methods for inhibiting pain |
| 01/31/2008 | US20080025999 Yersinia species compositions |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025995 Cross-Placenta Delivery System |
| 01/31/2008 | US20080025993 Method for Refolding Neisserial Nspa Protein |
| 01/31/2008 | US20080025991 Use of Aromatase Inhibitors for Treatment of Ectopic Pregnancy |
| 01/31/2008 | US20080025987 Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025978 High affinity ligand for p75 neurotrophin receptor |
| 01/31/2008 | US20080025975 Humanized antibodies against cd3 |
| 01/31/2008 | US20080025974 Toll-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation and viral infection |
| 01/31/2008 | US20080025973 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | US20080025972 Treating sex steriod responsive disorders |
| 01/31/2008 | US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit |
| 01/31/2008 | US20080025969 Treatment of Neurodegenerative Diseases by the Use of Gpr49 |
| 01/31/2008 | US20080025968 Methods and Agents for Immune Modulation and Methods for Identifying Immune Modulators |
| 01/31/2008 | US20080025966 Methods And Compositions For The Treatment Of Gastrointestinal disorders |
| 01/31/2008 | US20080025965 Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein levels |
| 01/31/2008 | US20080025964 Modified ribonucleases |
| 01/31/2008 | US20080025963 Compositions and methods for the treatment of CNS injuries |
| 01/31/2008 | US20080025962 Remedy for Alzheimer's Disease |
| 01/31/2008 | US20080025961 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | US20080025960 Detergents with stabilized enzyme systems |
| 01/31/2008 | US20080025959 Permeability of blood-brain barrier |
| 01/31/2008 | US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain |
| 01/31/2008 | US20080025949 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 01/31/2008 | US20080025948 Methods of Treatment Using Interferon-Tau |
| 01/31/2008 | US20080025947 Methods for enhancing the efficacy of IL-2 mediated immune responses |
| 01/31/2008 | US20080025946 Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| 01/31/2008 | US20080025945 treating hepatic fibrosis; liver cirrhosis; administering to a patient an effective low dose of IL-6, a mutein, fused protein, active fraction or circularly permutated derivative |
| 01/31/2008 | US20080025944 Combination Therapy for Immunostimulation |
| 01/31/2008 | US20080025943 Mixture comprising a first functionalized polymer in a first buffer; a second buffer at approximately physiological osmolality; a second functionalized polymer, a substance having at least one cell-adhesion site combined with the first mixture |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/31/2008 | US20080025914 Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug |
| 01/31/2008 | DE102006035577A1 Röntgendichtes Konjugat Radiopaque conjugate |
| 01/31/2008 | DE102006035083A1 Proteinbindende Methotrexat-Derivate und diese enthaltende Arzneimittel Protein-binding methotrexate derivatives and pharmaceutical compositions containing them |
| 01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
| 01/31/2008 | CA2842219A1 Inhibition of marcks-mediated degranulation by marcks n-terminal peptides in treating inflammation |
| 01/31/2008 | CA2694428A1 Compositions and methods for treatment of advanced prostate cancer |
| 01/31/2008 | CA2659262A1 Improved vaccines and methods for using the same |
| 01/31/2008 | CA2659012A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | CA2658806A1 Cytokine derivatives |
| 01/31/2008 | CA2658719A1 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 01/31/2008 | CA2658654A1 Exendin fusion proteins |